Navarro José-Tomás, Feliu Evarist, Grau Javier, Espinet Blanca, Colomer Dolors, Ribera Josep-Maria, Oriol Albert, Granada Isabel, Juncà Jordi, Millá Fuensanta
Servei d'Hematologia, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Barcelona.
Am J Hematol. 2007 Sep;82(9):849-51. doi: 10.1002/ajh.20859.
Chromosomal abnormalities in Ph-negative metaphases from patients with chronic myeloid leukemia (CML) treated with imatinib have been described in some cases. Trisomy 8 is the most frequent, but monosomy 7 has also been described. However, the association of these chromosomal alterations with myelodysplasia has been scarcely reported. We report the appearance of monosomy 7 in Ph-negative cells, associated with severe dysplasia, in two patients with CML treated with imatinib, with a different outcome: one with a transient evolution and the other evolving to acute myeloid leukemia.
在一些接受伊马替尼治疗的慢性髓性白血病(CML)患者的Ph阴性中期相中,已描述了染色体异常情况。8号染色体三体是最常见的,但也有7号染色体单体的报道。然而,这些染色体改变与骨髓发育异常的关联鲜有报道。我们报告了两例接受伊马替尼治疗的CML患者,其Ph阴性细胞中出现了7号染色体单体,并伴有严重发育异常,且转归不同:一例为短暂病程,另一例则进展为急性髓性白血病。